BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2005
View Archived Issues
Usnic acid exerts nongenotoxic anticancer effects in vitro
Read More
COL-3 blocks PKC activity and histamine release in mast cells
Read More
Lexicon Genetics updates small molecule drug discovery program
Read More
Agonists of mGlu8 and mGlu2/3 receptors may be useful for mood and anxiety disorders
Read More
Gene Logic to seek new therapeutic indications for Pfizer drugs
Read More
Antiviral effects reported for celgosivir in patients with chronic hepatitis C
Read More
Kissei launches Salagen for radiation-induced dry mouth in Japan
Read More
Santen to develop rivoglitazone for corneal and conjunctival epithelial disorders
Read More
Proof-of-concept study for DDP-733 in constipation-predominant IBS
Read More
Ispinesib and SB-743921 make progress under Cytokinetics and GSK alliance
Read More
ArQule changes focus, updates pipeline
Read More
AVI BioPharma begins HCV study for AVI-4065
Read More
FDA request further phase II study for Reverset prior to phase III
Read More
Phase I study investigates systemic delivery of Reolysin in solid tumors
Read More
Osteologix completes phase I study of NBS-101 for osteoporosis
Read More
Glycominds test may predict active MS
Read More
Validation of computerized prediction of polymorphs
Read More
Novel multifunctional agent for neuroprotection
Read More
A new class of antioxidants attenuates neurotoxicity in MPTP model of Parkinsonism
Read More
Dual CysLT1/ CysLT2 receptor antagonist for asthma
Read More
CE-590 useful for osteoporosis in men with low gonadal function
Read More
Oral LY-293111 safe in phase I dose-finding study in cancer patients
Read More
Trabectedin metabolism, excretion studied in humans
Read More
Angeliq receives FDA approval
Read More
DiObex receives fast track designation for Very Low Dose Glucagon
Read More
Critical Therapeutics' sNDA approved to manufacture and market Zyflo
Read More
Novel diagnostic assay for bipolar disorder claimed by Garvan Institute of Medical Research
Read More
TAK-536 prodrugs claimed by Takeda for cardiovascular disorders
Read More
AAV-GAD gene therapy reported effective in advanced PD
Read More
Patents reveal novel agents for asthma, COPD, etc.
Read More
